e performed a prospective, blind, controlled study on wound infection after implant surgery involving 41 procedures in patients infected with the human immunodeficiency virus (HIV) and 141 in HIV-negative patients. The patients were staged clinically and the CD4 cell count determined. Wound infection was assessed using the asepsis wound score. A risk category was allocated to account for presurgical contamination.
Infection is a serious complication of operations which involve implants in both trauma and elective surgery. Certain patients, such as those taking immunosuppressive drugs, have an increased risk of infection. In such patients the risk of wound sepsis must be weighed carefully against the potential benefits of surgery, and the use of implants in particular.
Patients who are infected with the human immunodeficiency virus (HIV) suffer progressive deterioration in immunity as indicated by a fall in the T-helper (CD4) cell count. Studies suggest that in such patients the risk of wound infection increases as the immune status deteriorates. [1] [2] [3] [4] We therefore undertook a prospective, blind, controlled study to quantify the incidence of wound infection after implant surgery in HIV-positive patients and to assess the role of the CD4 cell count as a marker of an increased risk of developing an infection.
Patients and Methods
All adult patients undergoing implant surgery were counselled for HIV testing and those who consented to testing were entered into the study. HIV testing. Two blood samples were taken immediately before the induction of anaesthesia. On the first sample HIV testing was undertaken using the HIV spot test (Genelabs Diagnostics Pte Ltd, Singapore). In those patients with a positive result, a CD4 cell count was undertaken on the second sample. All patients were clinically staged for HIV disease according to the WHO criteria. 5 This assessment was made by a neutral observer, blind to the HIV status, and was not seen by the operating surgeon. Wound scoring. Assessment of healing and infective complications was made using the asepsis wound scoring system 6 (Table I) as recommended by the Surgical Infection Study Group. 7 This describes the appearance of the wound and the necessity for further treatment, such as the administration of antibiotics. The maximum score is 70. It is very sensitive and allows objective appraisal of infection, and its severity. For the purpose of our study, a score of 0 to 10 was considered to represent normal wound healing, and a score of more than 10 an infection. This confers a sensitive, if arbitrary, definition of infection. A single neutral observer (CPL) recorded the scores at 5 days, 2 and 6 weeks, and at 3 months after operation. The highest score for each patient was adopted. Both the operating surgeons and the observer were blind to the HIV status of the patient. All patients were treated as potentially HIVpositive and suitable precautions were taken. Patients. A total of 180 patients consented to enter the study; 39 were HIV-positive and accounted for 41 (22%) of the 185 separate surgical implantation procedures. There was therefore a control group of 141 HIV-negative patients. As the follow-up data were incomplete for ten patients (1 HIV-positive) we analysed the data for only 170 patients who had 175 procedures. The mean age of the HIV-positive group was 37 years (21 to 54) and of the HIV-negative group 36 years (15 to 76). No patient had received antiretroviral drug therapy and none had diabetes, psoriasis, tuberculosis, or took steroids or other immunosuppressive medication. WHO staging. 5 The WHO clinical staging for HIV-positive patients was as follows: stage 0, 31 (80%), stage 1, 3 (8%), stage 2, 2 (5%), stage 3, 2 (5%); and not known, 1 (2%). CD4 cell counts. CD4 cell counts were divided into the groups recommended by the WHO staging criteria (Fig. 1) The cell counts were known for 37 of the HIV-positive patients and were less than the normal value of 1000 cells/ mm.
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Type of procedure. The procedures fell into four groups: internal fixation of fresh fractures, reconstruction for nonunion, and arthrodesis or arthroplasty for joint disease (Fig. 2 ).
There was a higher proportion of reconstructions in the HIV-positive group, and relatively more fixations of fresh fractures in the HIV-negative group. There may be an association between HIV disease and nonunion. Closed fractures were not treated surgically until the soft tissues were in a satisfactory condition, which was sometimes up to two weeks after injury.
All patients received a standard regime of antibiotic prophylaxis with a single intravenous dose of cephazolin (1 g) given at induction of anaesthesia. The method of skin preparation with chlorhexidine and cetrimide solution followed by povidone iodine was standardised. A standard sterile dressing was used and wounds were not inspected until the fifth postoperative day. Surgical drains were not used. Sutures were removed two weeks after operation. Type of implant (Fig. 3) . The implant was graded in order of increasing size: wires or screws, plate and screws, intramedullary nail, and arthroplasty. Both the HIV-positive and negative groups were well matched in regard to the distribution of types of implant. This gave a good indicator of the magnitude of the surgery, the length of incisions and the duration of procedures, although these variables were not individually analysed. Infection risk category. An infection risk category was allocated before operation to each procedure according to the state of the soft tissues as follows: 0, ideal surgical conditions as in closed fractures or elective procedures with healthy skin and 1, procedures on fresh open fractures, nonunion of previously open fractures, or previous surgery at that site. Analysis of the risk categories was separated to minimise its confounding influence. A total of 136 procedures (28 HIV-positive; 108, HIV-negative) was undertaken in risk category 0 and 39 (12 HIV-positive; 27 HIVnegative) in risk category 1. Statistical analysis. Analysis was carried out using the paired Student t-test with the level of significance being set at p ≤ 0.05.
Results

Defaulters.
Of the ten patients who did not complete follow-up for six weeks, none had wound problems up to Figure 4 . This definition of infection may portray a higher rate of infection than in other studies, but the listing of each infected patient in Table II qualifies closed fractures (5) showed a significant difference in the incidence of infection (5 v 1; p = 0.037). Within risk category 0, of the 28 HIV-positive patients only one (case 1) had a wound infection. No correlation was shown between the asepsis score and the CD4 cell count for patients in risk category 0 (correlation coefficient = 0.16; Fig. 5 ). In risk category 1 the numbers were too small to allow analysis of the effect of the CD4 cell count.
Discussion
The earlier studies of Hoekman et al 1 We considered that a prospective blind study should be undertaken in good surgical conditions, using prophylactic antibiotics and assessment of infection by wound scoring. The CD4 cell count was considered to be a more objective indicator of immune compromise than clinical staging. It is commonly used as the prime marker of the progression of the disease in developed countries. 10 Clinical staging is very observer-dependent, and may be confounded by comorbidity which is unrelated to HIV disease. The principal finding of our study was that in the absence of preoperative contamination, a low rate of wound infection was observed in HIV-positive patients (3.5%). This was similar to that (5%) observed in healthy controls (p = 0.396). Of the 28 HIV-positive patients in this group only one had superficial sepsis and this did not compromise Our study analysed two main variables within the HIVpositive group which might be expected to affect the incidence of wound infection. These are the degree of preoperative contamination (risk category) and the degree of immunocompromise (CD4 cell count). Of these, the risk category correlated with the incidence of infection (p = 0.036). A relationship with the CD4 cell count was not demonstrated (r = 0.13).
When uncontaminated patients (risk category 0) are being considered, a very large study would be required to reveal a possible correlation between a low CD4 cell count and an increasing risk of infection since infections are rare in this group regardless of the CD4 cell count. The most important issue is bacterial contamination, not the degree of host immunocompromise.
It has been suggested that late infections may arise around implants as HIV disease progresses. 2 We did not address this potential problem, but since patients were followed up for three months most of those with fractures had progressed to union. We would hope that further study will identify the risk of late infection. Should this represent a clinical problem, implants should be removed from HIV patients soon after union. Arthroplasty in HIV-positive patients presents a different issue as the implant cannot be removed without comprising the functional outcome. We believe that implant surgery can be undertaken safely in HIV-positive patients, if the skin is unbroken preoperatively and the surgical conditions are optimal. This applies even in the presence of profound immune compromise. In HIV-positive patients with preoperative contamination, however, the incidence of wound infection increases dramatically.
